Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,640 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

A Clinical Trial to Evaluate the Safety, Tolerability, and Pharmacokinetics of PGDM1400LS Alone and in Combination With VRC07-523LS and PGT121.414.LS in Healthy, HIV-uninfected Adult Participants

NCT05184452

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Bridge HIV CRS San Francisco, California, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • The Hope Clinic of the Emory Vaccine Center Atlanta, Georgia, United States
  • New Jersey Medical School Clinical Research Center CRS Newark, New Jersey, United States
View all 13 locations
View Trial Details
Completed

Package of Resources for Assisted Contact Tracing: Implementation, Costs, and Effectiveness

NCT05343390

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Balaka District Hospital Balaka, Malawi
  • Balaka OPD Health Centre Balaka, Malawi
  • Chiendausiku Health Centre Balaka, Malawi
  • Kalembo Health Centre Balaka, Malawi
View all 33 locations
View Trial Details
Completed

Pharmacokinetics of Antiretroviral Drugs in Lactating Women and Breastmilk Fed Infants Under 6 Months of Age in Botswana

NCT04862975

Conditions
Blood-Borne Infections, Breastmilk Fed Infants of Mothers on Select DOI, Communicable Diseases, +13 more
Locations
  • Botswana-UPenn Partnership Botswana, Gaborone, South Africa
  • Lesirane Clinic Botswana, Gaborone, South Africa
  • Mogoditshane Clinic KDC Botswana, Gaborone, South Africa
  • Old Naledi Clinic Botswana, Gaborone, South Africa
View Trial Details
Completed

Safety, Tolerability, and Immunogenicity Study of Homologous Ad26 Mosaic Vector Vaccine Regimens or Heterologous Ad26 Mosaic and MVA Mosaic Vector Vaccine Regimens With Glycoprotein 140 (gp140) for Human Immunodeficiency Virus (HIV) Prevention

NCT02315703

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Aurora, Colorado, United States
  • Miami, Florida, United States
  • Rockville, Maryland, United States
  • Boston, Massachusetts, United States
View Trial Details
Completed

A Study of 2 Different Regimens of Tetravalent Ad26.Mos4.HIV Prime Followed by Boost With Modified Vaccinia Ankara (MVA)-Mosaic OR Ad26.Mos4.HIV Plus a Combination of Mosaic and Clade C gp140 Protein in Human Immunodeficiency Virus (HIV) Type 1 Infected Adults on Suppressive Antiretroviral Treatment

NCT03307915

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beth Israel Deaconess Medical Center Boston, Massachusetts, United States
View Trial Details

Related conditions